Recent FDA updates in the areas of cardiac intervention, hypertension and arrhythmia disorders expand the pool of available treatments to new patient populations.This FDA Recap highlights FDA approval ...

Gabriela “Gabby” Schenone has played softball her entire life. From playing T-ball in a city rec league to becoming a ...

Optimized treatment reduces the mortality risk associated with chronic heart failure, leading to improvements in both ...

Implantable cardioverter-defibrillator therapy in patients with Brugada syndrome is effective for prevention of fatal arrhythmias.

ALEXANDRIA — An effort to put more automated external defibrillator cabinets in Alexandria’s downtown area was approved at ...

When a woman collapsed on an escalator at the Buffalo, New York, airport last June, Phil Clough knew what to do.

The Food and Drug Administration (FDA) has cleared the Jewel ® Patch Wearable Cardioverter Defibrillator (Patch-WCD) for adult patients aged 18 years and older who are at risk for sudden cardiac ...

Your heart has a sinus node that sends out electrical impulses to make your heart beat. If your sinus node is not working properly, your heart can beat too quickly. An ICD can take over the role of ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Element Science, a medical device and digital health company, announced that its innovative Jewel Patch Wearable Cardioverter Defibrillator (Patch-WCD) has received US Food and Drug Administration ...

If someone collapses in cardiac arrest, call 911, start CPR, and use an automated external defibrillator (AED) if it's available. Evidence suggests that these steps, a part of rapid bystander response ...

About the Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD) The Jewel® Patch-WCD is a novel, water resistant wearable cardioverter defibrillator designed to detect and treat ...